Avalo Therapeutics CMO Mittie Doyle disposes of common shares worth $20,000 - AVTX News | RalliesAvalo Therapeutics CMO Mittie Doyle disposes of common shares worth $20,000
A
AVTX• Avalo Therapeutics CMO exercises options and sells shares
- Avalo Therapeutics Chief Medical Officer Doyle Mittie exercised stock options for 1,000 shares at USD 12.65 on July 27, 2026.
- Mittie sold 1,000 shares at USD 20 the same day.
- Directly held common stock ended at 51,776 shares.
- Directly held stock options ended at 124,750.
NAAS
•
